Patents by Inventor Stanley D'Andrea

Stanley D'Andrea has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of Hepatitis C Virus
    Publication number: 20080107623
    Abstract: Macrocyclic peptides are disclosed having the general formula: wherein R3, R3?, R4, R6, R?, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: October 25, 2007
    Publication date: May 8, 2008
    Inventors: Stanley D'Andrea, Paul Scola
  • Inhibitors of Hepatitis C Virus
    Publication number: 20080107624
    Abstract: Macrocyclic peptides are disclosed having the general formula: wherein R3, R?3, R4, R6, R?, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: October 25, 2007
    Publication date: May 8, 2008
    Inventors: Stanley D'Andrea, Zhizhen Zheng, Paul Scola
  • Inhibitors of Hepatitis C Virus
    Publication number: 20080107625
    Abstract: Macrocyclic peptides are disclosed having the general formula: wherein R3, R3?, R4, R6, R?, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: October 25, 2007
    Publication date: May 8, 2008
    Inventors: Stanley D'Andrea, Paul Scola
  • Hepatitis C virus inhibitors
    Publication number: 20070099825
    Abstract: Macrocyclic peptides are disclosed having the general formula: wherein R?, R3, R3?, R4, R6, X, Q, and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: November 1, 2006
    Publication date: May 3, 2007
    Inventors: Stanley D'Andrea, Zhizhen Zheng, Jeffrey Campbell, Fiona McPhee, Andrew Good, Paul Scola
  • Hepatitis C virus inhibitors
    Publication number: 20070093414
    Abstract: Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: October 11, 2006
    Publication date: April 26, 2007
    Inventors: David Carini, Barry Johnson, Zhizhen Zheng, Stanley D'Andrea, Paul Scola
  • Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus
    Patent number: 7173004
    Abstract: Macrocyclic isoquinoline peptides are disclosed having the general formula: A compound of formula I: wherein R1 to R9, Q and W are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: February 6, 2007
    Assignee: Bristol-Myers Squibb Company
    Inventors: Fiona McPhee, Jeffrey Allen Campbell, Stanley D'Andrea, Zhizhen Barbara Zheng, Andrew Charles Good, David J. Carini, Barry L. Johnson, Paul Michael Scola, Kenneth M. Boy
  • Macrocyclic isoquinoline peptide inhibitors of Hepatitis C virus
    Publication number: 20050090432
    Abstract: Macrocyclic isoquinoline peptides are disclosed having the general formula: A compound of formula I: wherein R1 to R9, Q and W are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
    Type: Application
    Filed: April 16, 2004
    Publication date: April 28, 2005
    Inventors: Fiona McPhee, Jeffrey Campbell, Wenying Li, Stanley D'Andrea, Zhizhen Zheng, Andrew Good, David Carini, Barry Johnson, Paul Scola
  • Substituted cycloalkyl P1? hepatitis C virus inhibitors
    Patent number: 6878722
    Abstract: The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
    Type: Grant
    Filed: May 20, 2003
    Date of Patent: April 12, 2005
    Assignee: Bristol-Myers Squibb Company
    Inventors: Jeffrey Allen Campbell, Stanley D'Andrea, Andrew Good, Jianqing Li, Fiona Mcphee, Amy Ripka, Paul Michael Scola, Yong Tu
  • Substituted cycloalkyl P1' hepatitis C virus inhibitors
    Publication number: 20040077551
    Abstract: The present invention relates to tripeptide compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. In particular, the present invention provides novel tripeptide analogs, pharmaceutical compositions containing such analogs and methods for using these analogs in the treatment of HCV infection.
    Type: Application
    Filed: May 20, 2003
    Publication date: April 22, 2004
    Inventors: Jeffrey Allen Campbell, Stanley D'Andrea, Andrew Good, Jianqing Li, Fiona Mcphee, Amy Ripka, Paul Michael Scola, Yong Tu